Close

2017 Seen as a Challenge for Teva (TEVA), But Sticking with 'Buy' - Maxim

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. HCP
7. BSX
8. SNAP
9. PI
10. NOW


Go back to 2017 Seen as a Challenge for Teva (TEVA), But Sticking with 'Buy' - Maxim